December 2025 starts with a pullback in stocks following holiday trading
Quant Rockets Performance Highlights
Top Gainers Today
Reddit, Inc. (RDDT): +3.20%
Symbotic Inc. (SYM): +1.83%
Insmed Incorporated (INSM): +1.75%
Largest Decliners Today
Celestica Inc. (CLS): -7.56%
Sandisk Corporation (SNDK): -5.87%
Tempus AI, Inc. (TEM): -4.95%
In this market, a rules-based system like Quant Rockets is designed to identify individual stocks that are exhibiting unique strength, regardless of the index action. Today, that was evident in holdings like Reddit (RDDT), which surged 3.20% against the grain. Other bright spots included industrial automation company Symbotic (SYM) and biotech firm Insmed (INSM), which also posted solid gains. This highlights how a momentum strategy focuses on specific leadership trends that can operate independently of the broader market’s daily sentiment.
Of course, a risk-off day can also weigh on high-momentum names. The portfolio saw weakness in the technology and semiconductor space, with Celestica (CLS) declining 7.56% and Sandisk (SNDK) falling 5.87%.
These sharp pullbacks are a typical characteristic of volatile growth stocks when market sentiment sours. A systematic approach is built to handle this type of price action, managing positions based on predefined rules rather than reacting to short-term noise or fear.
Today’s performance provides a clear look at systematic trading in action. It’s not about being right on every stock every single day, but about maintaining exposure to a diversified basket of statistically strong names. As the market continues to digest economic data and potential
New Buy Signals
This section is only available for Quant Rocket Members. Start a trial today to get access.
Momentum Model Updates
Downgraded Outlook
Enjoy what you read? Share it below and be sure to tag @thetraderisk.
U.S. markets faced downward pressure today, with the S&P 500 and Dow Jones both closing in the red. The Dow’s nearly 350-point drop was influenced by weakness in large-cap names like Merck and Amgen, reflecting broader investor caution as we head into the final month of the year. This type of environment can be challenging, as widespread selling often makes it difficult to find pockets of strength.